SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Dog (Bitcoin) is a fully decentralized memecoin on the Bitcoin blockchain, backed by a community dedicated to onboarding millions of people to Bitcoin.  Dog is secured by the Bitcoin blockchain and exists on Bitcoin L1, marking a significant innovation compared to Bitcoin with just BTC. Dog is a Bitcoin Runes token with a minimal on-chain footprint, native to Bitcoin, and stored in UTXOs, just like Bitcoin.   What is the project about?  Dog does not do any paid promotion and is fully decentralized just like Bitcoin. Every influencer who chooses to post about Dog either received the airdrop or bought on secondary. Dog leverages the CC0 license to ensure that Dog is not owned by any single entity but rather by everyone. This had lead to the "DOG Army" independently creating art, apps, lotteries, plushies, websites, podcast, magazines, X account, IRL meetups, clothing lines, PFP collections, Telegram groups, and TikTok/Instagram about Dog.  What makes your project unique?  Dog was airdropped in the fairest memecoin launch ever. In early 2024, the Bitcoin Ordinals ecosystem came together in a full volunteer initiative that rewarded early adopters of the Ordinals Protocol. There was no team allocation, and 100% of the supply was airdropped for free. The airdrop algorithm favored neither whales nor influencers; it was determined by the community and made open-source for maximum transparency.

Dog (Bitcoin)

$DOG.X is trending as a Bitcoin-native meme coin launched via the Runes protocol, generating buzz for its fair distribution and strong community. Discussions highlight its potential to drive utility and transaction volume on the Bitcoin network, with many touting it as a leader in the current cycle. Community members are actively promoting its unique position compared to other meme coins and speculating about potential exchange listings.

Uniting the six native Japanese dog breeds. Kendu is the keeper of peace, the preserver of life, and the protector of unity. Join the pack!!

Kendu

Kendu is trending due to its strong community and growing holder count, signaling increasing interest and conviction. The community is actively discussing the potential for a major rally, driven by the expectation of a significant move in the dawg coin sector. Many believe $KENDU.X is undervalued and primed for substantial growth, emphasizing its real-world applications and brand development.

ProShares Trust - ProShares Short Dow30 -1x Shares

ProShares Short Dow30

$DOG is trending as the Bitcoin memecoin gains traction within the crypto community, with many touting its fair launch and strong community backing. Conversation highlights its potential to become the meme face of Bitcoin and draw comparisons to other popular memecoins. Community members are emphasizing its organic growth and decentralized nature.

DOVU

DOVU.X is trending as the community highlights its staking rewards and potential in the Real World Asset (RWA) space, particularly due to its "Trust Operating System." Recent news around partnerships and deals related to carbon credits and ecological projects may be acting as a catalyst. Community members are actively discussing its association with Hedera and potential for significant growth.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Summit Therapeutics is trending amid speculation around a potential licensing deal with AstraZeneca, with community members discussing the impact of recent trial data and a possible buyout. Some investors are analyzing trial endpoints and revenue potential, while others are comparing SMMT to competitors like IOVA. The community is closely watching for further developments and official announcements.

Gyrodyne LLC engages in the management of a portfolio of medical office and industrial properties. Its properties include Flowerfield, Port Jefferson Professional Park, Courtland Medical Center, and Grove. The company was founded by Peter James Papadakos in 1946 and is headquartered in St. James, NY.

Gyrodyne LLC

GYRO is trending due to a significant land sale agreement, potentially boosting its NAV. The community is discussing the stock's low float and potential for a substantial price increase, with some highlighting potential squeeze dynamics. Bullish sentiment appears to be building, driven by the company's real estate assets and upcoming shareholder meeting.

The Children's Place, Inc. engages in the provision of apparel, footwear, accessories, and other items for children. The firm also designs contracts to manufacture and sell fashionable and value-priced merchandise under the brand names of The Children’s Place, Baby Place, and Gymboree. It operates through The Children’s Place U.S. and The Children’s Place International segments. The Children’s Place U.S. segment refers to the company’s U.S. and Puerto Rico-based stores and revenue from its U.S. based wholesale business. The Children’s Place International segment is involved in the Canadian-based stores, revenue from the company’s Canadian-based wholesale business, as well as revenue from international franchisees. The company was founded by David Pulver and Clinton A. Clark in 1969 and is headquartered in Secaucus, NJ.

Childrens Place Inc

Children's Place is trending due to recent earnings and guidance, with discussions centered on a potential short squeeze given its high short interest. Community members are debating the company's turnaround efforts and the impact of new management, with some highlighting positive comparable DTC sales and others expressing concerns about financials and potential bankruptcy. The stock's low float and high short interest are fueling speculation about a significant price movement.

SSgA Active Trust - Financial Select Sector SPDR

Financial Select Sector SPDR Fund

XLF is trending as investors assess the potential impact of economic concerns and interest rate cut probabilities on the financial sector. Community discussion includes analysis of technical indicators like Elliott Wave patterns and pivot points, with some highlighting potential resistance levels. Broader market sentiment and sector rotation strategies are also influencing the conversation around financials.

K9 Finance, a Shibarium-based LSD platform, offers core DeFi services and acts as an official validator. Rewarding $KNINE holders with $BONE for block validation, it aims to drive DeFi adoption via the 'Roundtable of Dogs' DAO, which governs treasury and roadmap decisions.

K9 Finance DAO

K9 Finance DAO ($KNINE.X) is trending due to the upcoming K9 Quest Airdrop and its role as a key player in Shibarium's DeFi ecosystem, offering liquid staking for $BONE.X. The community is actively discussing staking strategies, DAO governance, and ways to earn rewards through Bonecrusher and ShibaSwap integration. With its innovative tri-token system and focus on real yield, K9 Finance is positioned to drive DeFi adoption on Shibarium.

Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course, and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna, and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

Intellia Therapeutics ($NTLA) is trending amidst discussions about gene editing, particularly after a safety event in a Phase 3 trial, although some analysts remain optimistic, citing the generally low incidence of such events and a possible link to prior medication. Despite the dip, the community is actively debating the stock's long-term potential, particularly its in-vivo approach, and potential acquisitions, noting Cathie Wood's ARK Invest has been adding to its position.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

TriCo Bancshares Rewards Shareholders With 9% Dividend Hike 

TCBK raises its quarterly dividend by nearly 9%, marking the 144th consecutive payout, reflecting a strong track record of consistent shareholder returns.

Stock Yards Reward Shareholders With 3.2% Dividend Hike, Shares Up

SYBT stock rises as investors react to its 3.2% dividend increase. Given decent liquidity, capital distribution seems sustainable.

M&T Bank Rewards Shareholders, Lifts Quarterly Dividend by 11.1%

MTB boosts shareholder returns with an 11.1% dividend hike to $1.50 per share and ongoing share repurchases.

Virtus Investment Rewards Shareholders With a 6.7% Dividend Hike

VRTS raises its quarterly dividend by 6.7% to $2.40 per share, marking the eighth straight year of annual increases.

Virtus Investment's July AUM Inches Up Sequentially on Net Inflows

VRTS's July AUM rose to $170.8B, lifted by ETF and institutional inflows despite U.S. retail fund outflows.

Virtus Investment Partners (VRTS) Surpasses Q2 Earnings Estimates

Virtus (VRTS) delivered earnings and revenue surprises of +0.64% and -0.38%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

MSCI (MSCI) Q2 Earnings Surpass Estimates

MSCI (MSCI) delivered earnings and revenue surprises of +0.24% and -0.12%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Virtus Investment Partners (VRTS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Virtus (VRTS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Best Momentum Stock to Buy for July 11th

EADSY, VRTS and IBKR made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on July 11, 2025.

Best Income Stocks to Buy for July 11th

ISNPY, VRTS and TELNY made it to the Zacks Rank #1 (Strong Buy) income stocks list on July 11, 2025.

Virtus Investment Partners, Inc. is an asset management company, which engages in the provision of investment management and related services to individuals and institutions. It offers financial solutions and products such as mutual funds, managed accounts, institutional, closed-end funds, Virtus variable insurance trust funds, and other portfolio. The company was founded on November 1, 1995, and is headquartered in Hartford, CT.

VRTS
Virtus Investment Partners Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest VRTS News

VRTS Virtus Investment Partners Inc